-
2025
In February
it was awarded the "Outstanding Achievement Award for Innovation and Strategic Initiation" by Yuhang District
In November
the self-developed scaffold for articular cartilage regeneration passed the review of the National Medical Products Administration (NMPA) and was approved to enter the Special Review Procedure for Innovative Medical Devices (acceptance number: CQTS2500315)
In December
the innovative project "Silk Biobased Materials Disrupting Chemical Material Manufacturing for Implantable Medical Devices" won the Excellent Enterprise Award in the 14th China Innovation and Entrepreneurship Competition Disruptive Technology Innovation Competition
-
2024
In March
the "Silk Fibroin Hernia Repair Patch" obtained the registration certificate for Class III medical devices and was launched on the market
In September
the industry standard titled "Tissue Engineering Medical Devices - Silk Fibroin," which was co-drafted by us, was officially released
In November
the group standard T/CHC 3-2024 "Silk Protein for Cosmetics", which was mainly participated in the development, has been released
the project "Clinical Translation of Osteochondral Tissue Engineering" that I participated in won the first prize of the 2023 Zhejiang Provincial Science and Technology Progress Award
-
2023
In January
"Silk Mesh" obtained the main document filing registration for medical devices from the National Medical Products Administration
In June
"Non-absorbable surgical suture" obtained the medical device registration certificate
"silk fibroin fibers" obtained the main document filing registration for medical devices from the National Medical Products Administration
In December
the "silk fibroin gel dressing" obtained the medical device registration certificate
-
2022
In April
the corporate standard "In-Vivo Evaluation of Implantable Medical Devices for Articular Cartilage Tissue Repair or Regeneration," which our company participated in the development of, was published
In November
the "silk fibroin hydrogel dressing" obtained a medical device registration certificate
"silk fibroin gel" obtained the main document filing registration for medical devices from the National Medical Products Administration
-
2021
In May
the main document for "silk fibroin tissue repair material (medical tissue patch)" obtained the registration of the main document for medical devices from the National Medical Products Administration
In August
the "silk fibroin" master file obtained the record registration of the medical device master file from the National Medical Products Administration
In October
the "disposable ribbon retractor" obtained the registration certificate for Class II medical devices
the national industry standard titled "Tissue Engineering Surgical Implants - Silk Fibroin" that I participated in the formulation of, was approved for establishment
-
2020
In February
the industry standard "Evaluation of Osteogenic Induction Performance of Demineralized Bone Material in Vivo for Allogeneic Repair Materials," which our company participated in the development of, was published
In March
the company's medical device "Articular Cartilage Regeneration Scaffold" obtained the clinical trial approval for medical devices from the National Medical Products Administration
In June
the "silk fibroin film dressing" obtained the registration certificate for Class III medical devices and was launched on the market
-
2019
In May
the technology team's research and development project won the second prize for science and technology from the Chinese Society for Biomaterials
In November
the technology team's research and development project won the second prize of Shandong Province Science and Technology Award
In December
the technical team's research and development project won the first prize for technological invention from the Ministry of Education
-
2018
In May
the silk fibroin sterile wound dressing entered the priority approval process for medical devices at the National Medical Products Administration
-
2017
In March
the company's R&D center was awarded the title of "Yuhang District Technology Enterprise R&D Center"
In June
Dr. Zhao Hongshi, a key R&D personnel of the company, was awarded the title of "Yuhang Craftsman" in the first session
-
2016
In March
the technology team's research and development project won the second prize of Weihai Science and Technology Award
In December
the DBM industry standard was officially approved for establishment by the National Standards Committee
-
2015
In February
the technical team won the first prize of Weihai Science and Technology Award
In April
it was approved as a special project for intelligent biomaterials under the "863 Program" during the 13th Five-Year Plan period
the R&D building project of Zhejiang Xingyue Regenerative Medicine Industrial Park was completed and accepted
In November
it was approved to establish a postdoctoral research station in Zhejiang Province
-
2014
In April
Dr. Wang Yanyan, a research and development backbone of the company, was selected for the "Thousand Talents Plan" in Yuhang District
In September
the research and development project of the Organizational Engineering New Materials Project was shortlisted for the Zhejiang Province Major Science and Technology Special Project
In October
the R&D building of Zhejiang Xingyue Regenerative Medicine Industry Project was completed and the main quality acceptance was completed
-
2013
In April
Dr. Zhao Hongshi, a key R&D personnel of the company, was selected into the "Thousand Talents Program" of Yuhang District
In September
the biological sterile wound dressing and medical tissue patch obtained the CE certification from the European Union
In October
the first new medical technology, ABioC tissue regeneration technology, was promoted and implemented in the field of sports medicine
the main structure of the "Zhejiang Xingyue Regenerative Medicine Industrial Park" project was completed
-
2012
In March
it became the main undertaking unit of the "863" project of the 12th Five-Year Plan for tissue regeneration technology
In September
the company's medical silk material project was selected as a "Key Technological Innovation Project in Zhejiang Province"
In October
the construction of the "Zhejiang Xingyue Regenerative Medicine Industrial Park," covering an area of 20 acres, was initiated
-
2011
In March
the Trade Union Committee of Zhejiang Xingyue Biotechnology Co., Ltd. was established
In September
the Class II and Class III "Medical Device Operating Enterprise License" was approved
-
2010
In April
a team of overseas returnee Ph.D.s joined hands with Xingyue Group to establish "Xingyue Biotech"
In June
the first batch of high-level overseas talents settled in Zhejiang Overseas High-level Talents Entrepreneurship and Innovation Park
In December
the company's 3,000 square meter medical device GMP workshop was completed and passed inspection by a third-party organization
